Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 4,045.00
+120.00 (3.06%)
At close: Jun 12, 2026
Chevron Lubricants Lanka Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 243.37 billion as of June 12, 2026. Its market cap has decreased by -23.50% in one year.
Market Cap
243.37B
Enterprise Value
263.35B
Revenue
54.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,045.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 243.37B, an increase of 235.91%. That is a compound annual growth rate of 6.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 243.37B | 21.27% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 385.17B |
| Samyang Biopharm | 377.74B |
| HEM Pharma | 337.28B |
| NOVAREX | 249.09B |
| CellBion | 236.30B |
| DAE HWA Pharmaceutical | 182.35B |
| High Tech Pharm | 148.76B |
| GC WellBeing | 145.27B |